Faconi Anemia Clinical Trials Faconi Anemia RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase I/II Study of FP-045 in Patients With Fanconi Anemia
Condition:   Fanconi Anemia Intervention:   Drug: FP-045 Sponsor:   Foresee Pharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2020 Category: Research Source Type: clinical trials